BULKAMID Uses, Dosage, Side Effects and more
BULKAMID is under investigation in clinical trial NCT00629083 (Bulking Agents for the Treatment of Stress Urinary Incontinence in Females).
| Attribute | Details |
|---|---|
| Trade Name | BULKAMID |
| Generic | Polyacrylamide (crosslinked; 2 mole percent bisacrylamide) |
| Polyacrylamide (crosslinked; 2 mole percent bisacrylamide) Other Names | BULKAMID |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
